Berlin, Germany

Fred Windt-Hanke

This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1989-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1989-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Fred Windt-Hanke

Introduction

Fred Windt-Hanke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal agents, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance the efficacy of medicinal compounds.

Latest Patents

Among his latest patents is a groundbreaking invention related to medicinal agents with sustained action. This patent claims medicinal agents that exhibit sustained release of active compounds, which contain a solid active ingredient that is poorly soluble in water. The invention is characterized by the active compound being distributed in microcrystalline form or as a molecular dispersion on pellets, which are then covered by a membrane that has retarded permeability concerning the active compound. Another significant patent is the Nifedipine combination preparation, which showcases his expertise in creating effective pharmaceutical formulations.

Career Highlights

Fred Windt-Hanke is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Schering has allowed him to focus on innovative medicinal solutions that address various health challenges.

Collaborations

Throughout his career, Fred has collaborated with esteemed colleagues such as Christian Fechner and Manfred Albring. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Fred Windt-Hanke's contributions to the field of medicinal agents demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of pharmaceutical science and a dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…